Literature DB >> 9589903

Interactions between Epstein-Barr virus and the cell cycle control machinery.

A J Sinclair1, M Fenton, S Delikat.   

Abstract

Epstein-Barr virus (EBV) persists in the majority of the world's human population. In the majority of cases the infection is asymptomatic, but EBV is associated with a number of human diseases, such as infectious mononucleosis, Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin's disease, gastric carcinomas and other lymphomas and lymphoproliferative diseases. In this review the evidence linking EBV with these diseases is reviewed together with recent advances in understanding the interactions between EBV and the cell cycle control machinery.

Entities:  

Mesh:

Year:  1998        PMID: 9589903     DOI: 10.14670/HH-13.461

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  4 in total

1.  The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.

Authors:  Tathagata Choudhuri; Subhash C Verma; Ke Lan; Masanao Murakami; Erle S Robertson
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

2.  Divergent requirements for the MAPK(ERK) signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters.

Authors:  M Fenton; A J Sinclair
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Loss of functional pRB is not a ubiquitous feature of B-cell malignancies.

Authors:  A J Sinclair; V Frost
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  The landscape of human proteins interacting with viruses and other pathogens.

Authors:  Matthew D Dyer; T M Murali; Bruno W Sobral
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.